Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 18c

Calidi Biotherapeutics (NYSE: CLDI) reported Q1 EPS of ($0.18).

For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) click here.

You May Also Be Interested In

• Activist investors push Seer, Inc. to disclose go-private timeline
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
• Foot traffic at Taco Bell for week of August 3 down 8%, compared to a near 20% decline in mid-July - Placer.AIdata